REGN2222

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN2222, covering 2016-11-04 to 2016-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Blood Concentrations of Two Formulations of REGN2222 in Healthy Subjects [Phase 1]